Zusammenfassung
Depressive Störungen und somatische Erkrankungen sind in der Allgemeinbevölkerung sehr verbreitet. Ein Zusammengehen von Depression und körperlicher Krankheit ist also schon allein aus statistischen Gründen überzufällig zu erwarten. Die Betrachtung des Zusammenhangs von Depression und körperlicher Krankheit wirft eine Reihe konzeptueller, nosologischer und diagnostischer Fragestellungen auf. So können zunächst konzeptuell ganz unterschiedliche Modelle diskutiert werden, wie diese Relation eines gemeinsamen Auftretens beschaffen sein könnte. Abbildung 6.1 vermittelt einen orientierenden Einblick in die Komplexität dieser Koexistenz bzw. Komorbidität. Lediglich für das Modell 3 und mit Einschränkungen für das Modell 5 kann in einer nosologischen Perspektive das traditionelle Konzept einer organisch depressiven Störung im engeren Verständnis diskutiert werden (Kapfhammer 2001).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Anda R, Williamson D, Jones D et al. (1993) Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of US adults. Epidemiology 4:285–294.
Balogh S, Fitzpatrick DF, Hendricks SE, Paige SR (1993) Increases in heart rate variabilty with successful treatment in patients with major depression disorder. Psychopharmacol Bull 29:201–206.
Barefoot JC, Schroll M (1996) Symptoms of depression, acute myocardial infarction, and total mortality in a community sample. Circulation 93:1976–1980.
Barefoot JC, Williams RB (2000) Antidepressant use and the risk of myocardial infarction. Am J Med 108:87–88.
Bellush LL, Reid SG (1994) Metabolic and neurochemical profiles in insulin-treated diabetic rats. Am J Physiolol 266:R87–R94.
Botow PN, Hiller JE, Price MA, Thackway SV, Kricker A, Tennant CC (2000) Epidemiological evidence for a relationship between life events, coping style, and personality factors in the development of breast cancer. J Psychosom Res 49:169–181.
Carney C (1999) Endocrine disorders. In: Robinson RG, Yates WR (eds) Psychiatric treatment of the medically ill. Marcel Dekker, New York, Basel, pp 155–180.
Carney RM, Freedland KE, Lustman PJ et al. (1994) Depression and coronary disease in diabetic patients: A 10-year follow-up. Psychosom Med 56:149.
Carney RM, Rich MW, Freedland KE, Siani J (1988) Major depressive disorder predicts cardiac events in patients with coronary artery disease. Psychosom Med 50:627–633.
Ciaramella A, Poli P (2001) Assessment of depression among cancer patients: The role of pain, cancer type and treatment. Psycho-Oncology 10:156–165.
Cohen HW, Gibson G, Alderman MH (2000) Excess risk of myocardial infarction in patients treated with antidepressant medications: Association with tricyclic agents. Am J Med 108:2–8.
Cohen-Cole SA, Stoudemire A (1987) Major depression and physical illness. Special considerations in diagnosis and biologic treatment. Psychiatr Clin North Am 10:1–17.
Cull A (1990) Invited review: Psychological aspects of cancer and chemotherapy. J Psychosom Res 34:129–40.
Derogatis LR, Morrow GR, Fetting J et al. (1983) The prevalence of psychiatric disorders among cancer patients. JAMA 249:751–757.
DiMatteo MR, Lepper HS, Croghan TW (2001) Depression is a risk factor for non-compliance with medical treatment. Meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 160:2101–2107.
Eaton WW, Armenian H, Gallo J, Pratt L, Ford DE (1996) Depression and risk for onset of type II diabetes. Diabetes Care 19:1097–1102.
Endicott J (1984) Measurement of depression in patients with cancer. Cancer 53:2243–2248.
Everson SA, Goldberg DE, Kaplan GA et al. (1996) Hopelessness and the risk of mortality and incidence of myocardial infarction and cancer. Psychosom Med 58:113–121.
Faller H (2001) Krankheitsbewaltigung und Überlebenszeit bei Krebskranken. Psychotherapeut 46:20–35.
Fava M, Rosenbaum JF, Pava J et al. (1993) Anger attacks in unipolar depression, part 1: Clinical correlates and response to fluoxetine treatment. Am J Psychiatry 150:1153–1163.
Frasure-Smith N, Lesperance F, Talajic M (1993) Depression following myocardial infarction: Impact on 6-month survival. JAMA 270:1819–1861.
Frasure-Smith N, Lesperance F, Talajic M (1995) Depression and 18-month prognosis following myocardial infarction. Circulation 91:999–1005.
Glassman AH, Shapiro PA (1998) Depression and the course of coronary artery disease. Am J Psychiatry 155:4–11.
Gonzalez MB, Snyderman TB, Colket JT et al. (1996) Depression in patients with coronary artery disease. Depression 4:57–62.
Goodnick PJ (1997) Diabetes mellitus and depression: Issues in theory and treatment. Psychiatr Annals 27:353–359.
Goodnick PJ, Henry JH, Buki VM (1995) Treatment of depression in patients with diabetes mellitus. J Clin Psychiatry 56:128–136.
Harrison J, Maguire P (1994) Predictors of psychiatric morbidity in cancer patients. Br J Psychiatry 165:593–598.
Helz JW, Templeton B (1990) Evidence of role of psychosocial factors in diabetes mellitus: A review. Am J Psychiatry 147:1275–1282.
Holland JC, Lesko LM (1989) Chemotherapy, endocrine therapy, and immunotherapy. In: Holland JC, Rowland JH (eds) Textbook of psychooncology. Oxford University Press, New York, Oxford, pp 141–162.
Holland JC, Romano SJ, Heiligenstein JH, Tepner RG, Wilson MG (1998) A controlled trial of fluoxetine and desipramine in depressed women with advanced cancer. Psycho-Oncology 7:291–300.
Honig A, Maes M (2000) Psychoimmunology as a common pathogenetic pathway in myocardial infarction, depression and cardiac death. Curr Opin Psychiatry 13:661–664.
Jacobson AM, Rand LI, Hauser ST (1985) Psychologic stress and glycemic control: A comparison of patients with and without proliferative diabetic retinopathy. Psychosom Med 47:372–381.
Kalash GR (1998) Psychotropic drug metabolism in the cancer patient: Clinical aspects of management of potential drug interactions. Psycho-Oncology 7:307–320.
Kapfhammer HP (1993) Epidemiologic der Depression im Rahmen von Tumorerkrankungen. In: Staab HJ, Ludwig M (Hrsg) Depression bei Tumorpatienten. Thieme, Stuttgart, S 29–41.
Kapfhammer HP (1998) Internistische Aspekte der Behandlung mit Antidepressiva. In: Hewer W, Lederbogen F (Hrsg) Internistische Probleme bei psychiatrischen Erkrankungen. Enke, Stuttgart, S 51–87.
Kapfhammer HP (1999 a) Depressiv-ängstliche Störungen bei somatischen Krankheiten. In: Möller HJ, Laux G, Kapfhammer HP (Hrsg) Psychiatrie und Psychotherapie. Springer, Berlin, Heidelberg, S 1488–1519.
Kapfhammer HP (1999 b) Psychopharmakotherapie depressiver Störungen bei somatischen Erkrankungen: SSRI und andere neuere Antidepressiva. In: Diefenbacher A (Hrsg) Aktuelle Konsiliarpsychiatrie und -psychotherapie. Thieme, Stuttgart New York, S 131–160.
Kapfhammer HP (2001) Begleitdepressionen bei körperlichen Krankheiten - Epidemiologic und Diagnostik. Clinicum (im Druck).
Kasper S, Jung B (1995) Psychiatrisch relevante Nebenwirkungen der nichtpsychopharmakologischen Pharmakotherapie. Nervenarzt 66:649–661.
Katon W, Sullivan DM (1990) Depression and chronic medical illness. J Clin Psychiatry 51 (Suppl 6):3–11.
Ladwig KH, Roll G, Breithardt G, Budde T, Borggrefe M (1994) Post-infarction depression and incomplete recovery 6 months after acute myocardial infraction. Lancet 342:20–23.
Lebinger TG, Saenger P, Fukushima DK et al. (1983) Twenty-four-hour cortisol profiles demonstrate exaggerated nocturnal rise in diabetic children. Diabetes Care 6:506–509.
Leedom L, Meehan WP, Procci W et al. (1991) Symptoms of depression in patients with type II diabetes mellitus. Psychosomatics 32:280–286.
Levenson JL, Bemis C (1991) The role of psychological factors in cancer onset and progression. Psychosomatics 32:124–132.
Levenson JL, Dwight M (2000) Cardiology. In: Stoudemire A, Fogel BS, Greenberg DB (eds) Psychiatric care of the medical patient, 2nd edn. Oxford University Press, Oxford New York, pp 717–731.
Liang LP, Dunn SM, Gorman A, Stuart-Harris R (1990) Identifying priorities of psychosocial need in cancer patients. Br J Cancer 62:1000–1003.
Lloyd GG, Matthews KA, Wing RR et al. (1992) Psychosocial factors and complications of IDDM: The Pittsburgh Epidemiology of Diabetes Complications: Study VIII. Diabetes Care 15:166–172.
Lloyd GG, Steel JM, Young RJ (1987) Eating disorders and psychiatric morbidity in patients with diabetes mellitus. Psychother Psychosom 48:189–195.
Lustman PJ, Amado H, Wetzel RD (1983) Depression in diabetics: A critical review. Compr Psychiatry 1:65–74.
Lustman PJ, Clouse RE, Freedland KE (1998) Management of major depression in adults with diabetes mellitus: Implications of recent clinical trials. Sem Clin Neuropsychiatry 3:102–114.
Lustman PJ, Griffith LS, Clouse RE (1988) Depression in adults with diabetes: Results of a 5-year follow-up study. Diabetes Care 11:605–612.
Lustman PJ, Griffith LS, Clouse RE et al. (1986) Psychiatric illness in diabetes mellitus: Relationship to symptoms and glucose control. J Nerv Ment Dis 174:736–742.
Lustman PJ, Griffith LS, Freedland KE et al. (1997) The course of major depression in diabetes. Gen Hosp Psychiatry 19:138–143.
MacKenzie R, Trulson M (1978) Effects of insulin and streptozotozin-induced diabetes on brain tryptophan and sertonin metabolism in rats. J Neurochem 30:205–211.
Maes M (2001) Interleukin-1β and the etiology of depression. Acta Psychiatr Scand 103: 161–162.
Markovitz JH, Shuster JL, Chitwood WS, May R, Tolbert LC (2000) Platelet activation in depression and effects of sertraline treatment: An open-label study. Am J Psychiatry 157:1006–1008.
Massie MJ, Holland JC (1990) Depression and the cancer patient. J Clin Psychiatry 51 (Suppl 7):12–19.
McDaniel JS, Musselman DL, Porter MR, Reed DA, Nemeroff CB (1995) Depression in patients with cancer. Diagnosis, biology, and treatment. Arch Gen Psychiatry 52:89–99.
Menkes DB, MacDonald JA (2000) Interferons, serotonin and neurotoxicity. Psychol Med 30:259–268.
Murrell SA, Himmelfarb S, Wright K (1983) Prevalence of depression and its correlates in older adults. Am J Epidemiol 117:173–185.
Musselman DL, Evans DL, Nemeroff CB (1998) The relationship of depression to cardiovascular disease. Epidemiology, biology, and treatment. Arch Gen Psychiatry 55:580–592.
Peninx BWJ, Beckman ATF, Honig A et al. (2001) Depression and cardiac mortality. Results from a community-based longitudinal study. Arch Gen Psychiatry 58:221–227.
Petitto JM, Evans DL (1998) Treatment of depression in individuals with cancer: Implications of antidepressant pharmacotherapy. Sem Clin Neuropsychiatry 3:131–136.
Popkin MK, Callies AL, Lentz RD et al. (1988) Prevalence of major depression, simple phobia, and other psychiatric disorders in long-standing type I diabetes mellitus. Arch Gen Psychiatry 45:64–68.
Robinson N, Fuller H, Edmeades SP (1988) Depression and diabetes. Diabet Med 5:268–274.
Rodin G, Craven J, Littlefield C (1991) Depression in the medically ill. Brunner Mazel, New York.
Roose SP, Glassman AH, Attia E, Woodring S, Giardina EGV, Bigger JT Jr (1998b) Cardiovascular effects of fluoxetine in depressed patients with heart disease. Am J Psychiatry 155:660–665.
Roose SP, Laghrissi-Thode F, Kennedy JS et al. (1998 a) Comparison of paroxetine and nor-triptyline in depressed patients with ischemic heart disease. JAMA 28:287–291.
Rosmark B, Berne C, Holmgren S et al. (1968) Eating disorders in patients with insulin-dependent diabetes mellitus. J Clin Psychiatry 47:547–550.
Roth AJ, McClera KZ, Massie MJ (2000) Oncology. In: Stoudemire A, Fogel BS, Greenberg DB (eds) Psychiatric care of the medical patient, 2nd edn. Oxford University Press, Oxford New York, pp 733–756.
Schleifer SJ, Macari-Hinson MM, Coyle DA et al. (1989) The nature and course of depression following myocardial infarction. Arch Intern Med 49:1785–1789.
Shapiro PA, Lidagoster L, Glassman AH (1997) Depression and heart disease. Psychiatr Annals 27:347–352.
Slaughter JR, Jain A, Holmes S, Reid JC, Bobo W, Sherrod NB (2000) Panic disorder in hospitalized cancer patients. Psycho-Oncology 9:253–258.
Spiegel D (1991) Psychosocial aspects of cancer. Curr Opin Psychiatry 4:889–897.
Spiegel D (1994) Krebs und Depression. Verhaltenstherapie 4:81–88.
Strain J J, Caliendo G, Himelein C (1998) Using computer databases to predict and avoid drug-drug interactions in the cancer patient requiring psychotropics. Psycho-Oncology 7:321–332.
Strik JJ, Honig A, Lousberg R et al. (2000) Efficacy and safety of fluoxetine in the treatment of patients with major depression after first myocardial infarction: Findings from a double-blind, placebo-controlled trial. Psychosom Med 62:783–789.
Sullivan M, LaCroix A, Russo J, Swords E, Sornson M, Katon W (1999) Depression in coronary heart disease. What is the appropriate diagnostic threshold? Psychosomatics 40: 286–292.
Trulson MH, Himmel C (1985) Effects of insulin and streptozotozin-induced diabetes on brain norepinephrine metabolism in rats. J Neurochem 44:1873–1876.
Twillman RK, Manetto C (1998) Concurrent psychotherapy and pharmacotherapy in the treatment of depression and anxiety in cancer patients. Psycho-Oncology 7:285–290.
Wells KB, Golding JM, Burnam MA (1989) Affective, substance use, and anxiety disorders in persons with arthritis, diabetes, heart disease, high blood pressure, or chronic lung disease. Gen Hosp Psychiatry 11:320–327.
Weyerer S, Hewer W, Pfeifer-Kurda et al. (1989) Psychiatric disorders and diabetes: Results from a community study. J Psychosom Res 33:633–640.
Wing RR, Marcus MD, Blair EH et al. (1987) Depressive symptomatology in obese adults with type II diabetes. Diabetes Care 13:170–172.
Yates WR (1999) Epidemiology of psychiatric disorders in the medically ill. In: Robinson RG, Yates WR (eds) Psychiatric treatment of the medically ill. Marcel Dekker, New York Basel, pp 41–64.
Zabora J, Brintzenhofeszoc K, Curbow B, Hooker C, Piantadosi S (2001) The prevalence of psychological distress by cancer site. Psycho-Oncology 10:19–28.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Kapfhammer, H.P. (2002). Organisch depressive Störungen: Koronare Herzerkrankung, Diabetes mellitus, Krebs. In: Laux, G. (eds) Depression 2000. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59394-9_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-59394-9_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-63963-0
Online ISBN: 978-3-642-59394-9
eBook Packages: Springer Book Archive